Shares of Aurobindo Pharma today fell by 4.5 per cent after the company reported decline in its net profit for the fourth quarter ended March 2018.
The stock dropped 4.23 per cent to end at Rs 579.50 on BSE. During the day, it tumbled 7.45 per cent to Rs 560.
On NSE, shares of the company plunged 4.50 per cent to close at Rs 578.
In terms of equity volume, 2.94 lakh shares of the company were traded on BSE and over 65 lakh shares changed hands on the NSE during the day.
Aurobindo Pharma yesterday reported a marginal decline in its net profit at Rs 528.5 crore for the fourth quarter ended March 2018.
The company had posted a net profit of Rs 532.5 crore during the same period of 2016-17 fiscal.
Revenue from operations, however, rose to Rs 4,049.1 crore for the fourth quarter, as compared with Rs 3,641.6 crore in the similar period of 2016-17 fiscal, Aurobindo Pharma said in a regulatory filing.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app